The global Healthcare Specialty Enzymes market size is expected to be worth around US$ 4.8 billion by 2030, according to a new report by Vision Research Reports.
The global Healthcare Specialty Enzymes market size was valued at US$ 3.4 billion in 2020 and is anticipated to grow at a CAGR of 7.2% during forecast period 2021 to 2030.
Increasing penetration of in medical applications serves to be a key driving factor for the market. This is also supplemented by extensive research studies being carried out to explore the potential of enzymes in diagnosis as well as therapy. Diagnostic serum enzymes have gained significant attention for the quantification of these offers useful insights regarding abnormal tissue or an organ and help in predicting sites that are susceptible to tissue damage.
Certain products such as aldolase, Creatine Phosphokinase (CPK), gamma-glutamyl transpeptidase, lactic dehydrogenase, lipase, and transaminases are routinely adopted for disease diagnosis. Aldolase is preferably used in the early-stage diagnosis of viral hepatitis as well as advanced prostate cancer. Whereas, CPK has caught the attention of healthcare professionals in terms of both diagnosis and research. CPK tests are performed to diagnose cardiac abnormalities, muscle-associated conditions along with differentiation of post-operative infection from malignant hyperthermia. Thus, the use of enzyme products expanding across various diagnostic applications is set to propel the demand for these products in the healthcare industry.
The carbohydrases segment accounted for the largest revenue share of approximately 30.0% in 2020 as they are utilized on a wide scale in the biotechnology and diagnostics industry across the globe. Several companies offer amylase suitable for lab-based complications. For instance, Amano Enzyme Inc.; American Laboratories, Inc.; Analyticon Biotechnologies AG; Angstrom Biotech Pvt. Ltd.; and Lab Care Diagnostics (India) Pvt. Ltd. offers amylase that can be used in the diagnosis of pancreatic disorders or lab-scale research protocols.
The transition from laboratory-based diagnosis protocols to molecular diagnostics has been witnessed in recent years. This is attributed to the need to avoid labor-intensive microbiology diagnostic tests across laboratories and diagnostic centers.
In addition, molecular diagnostic tests serve to be potent alternatives for conventional diagnostic modalities as they offer faster results. This is set to contribute to the revenue generated by this segment in the market for healthcare specialty enzymes as both polymerases and nucleases play a pivotal role in molecular diagnostics.
The microbial enzymes segment accounted for the largest revenue share of 46.1% in 2020 among the other sources available in the market for healthcare specialty enzymes. This is attributed to unique characteristics induced in the enzymes derived from microbes. Fermented microbial enzyme products offer several advantages including broad ranges of pH, temperatures, and varied specificities regarding the substrate. The use of microbes for the production of proteases has increased considerably over the years as present demand for proteases cannot be sufficed by the plant as well as animal-derived proteases. Thus, microorganisms serve to be the potent alternative for the manufacturing of proteases on large scale.
Enzyme engineering aids in the manufacturing of an effective and diverse array of products that have useful implications in diagnostics. Thus, organism/source selection plays a pivotal role in maintaining the functionality of the enzyme. The source selection is done based on the potential of organisms to give the desired yield in shorter durations with minimal requirements for secondary metabolites.
The clinical chemistry segment dominated the market for healthcare specialty enzymes and accounted for over 28.0% of revenue share in 2020 owing to the higher usage of these enzymes in the clinical analysis. Enzymes are largely used as reagents in the clinical chemistry applications whereas, the significant potential of polymerases and nucleases in diagnosis, as well as for biotechnology research, has highly contributed to the revenue generated by molecular diagnostics in the market for healthcare specialty enzymes.
Immunodiagnostics and immunoassays are anticipated to witness the fastest growth in the market for healthcare specialty enzymes in the coming years. Several market players are keen on integrating enzyme-based products with diagnostic immunodiagnostic techniques, for instance, Thermo Fisher Scientific Inc. offers enzyme-based products that can be used in immunodiagnostic applications.
Healthcare specialty enzyme products have gained immense importance in molecular cloning techniques and have become an integral part of routine laboratory applications. This has propelled various manufacturers to develop products from different origins that can create and modify nucleic acids. Hence, it is important to select apt enzyme that is suitable for a certain task. The most applied enzyme products in the molecular cloning research activities are polymerases, ligases, nucleases, phosphatases, methylases, and topoisomerases.
Healthcare specialty enzymes find tremendous applications in the research as well as clinical space, thereby accounted for the largest revenue share of 64.7% in 2020. In addition, this sector is expected to witness rapid growth supplemented by robust funding in the biotechnology industry from national organizations as well as corporate companies. A shift towards products that are derived from biological compounds is a recent trend observed among the drug manufacturers in the U.S.
This industry is set to witness spurring growth over the coming years, with the specialty sector displaying the highest growth as compared to the moderately growing industrial sector. These enzymes are categorized as a low volume with high value-added usages. Factors such as declining costs of DNA sequencing, rising awareness regarding novel healthcare specialty enzyme products, and the demographic transition has propelled the utilization of healthcare specialty enzymes across diagnostic as well as research activities.
Infectious diseases dominated the market for healthcare specialty enzymes with the largest revenue share of 28.0% in 2020. The application of enzyme biomarker tests has led to the estimated dominance of the segment. In addition, the current pandemic outbreak of COVID-19 across the globe is further set to result in an exponential growth rate of this segment from 2020 to 2027. For instance, an Indian biotechnology company namely, Richcore Lifesciences is set to introduce 2pivotalenzyme components, applied largely across theCOVID-19 diagnostic kits based on Reverse Transcription Polymerase Chain Reaction (RT-PCR).
Also, a U.S. based manufacturer - Creative Enzymes has expanded the portfolio of healthcare specialty enzymes, acknowledging the present use of Nucleic Acid Test (NAT) and serological tests for COVID-19 diagnosis. However, oncology-based applications are set to witness the fastest growth as a result of increasing adoption in R&D for the disease etiology studies.
Laboratories held the maximum revenue share of 44.8% in 2020 in the market for healthcare specialty enzymes. This is due to the substantial usage of enzymatic products in research operations. Laboratories are keen on adopting healthcare specialty enzyme products for chronic disease diagnosis such as infectious diseases, inflammatory disorders, and myocardial infarction. Research targeted towards exploring the potential of healthcare specialty enzyme products in designing effective therapies is also on the rise.
Enzyme based diagnostic tests are largely adopted across hospitals to design effective therapy, especially for the treatment of cardiac and oncology patients. For instance, the troponin enzyme test is one of the most preferred cardiac enzyme tests in recent years. Hospitals prefer to measure troponin post 4 to 6 hours of the symptoms. In some cases, hospitals may also perform the test again after around 12 hours.
North America dominated the market for healthcare specialty enzymes and accounted for the largest revenue share of 38.2% in 2020. The region displayed the highest contribution of more than USD 900.0 million to the market, attributed to the high penetration of enzyme technology. In addition to this, expanding sales and distributors observed in the region are anticipated to boost the demand for healthcare specialty enzymes in the region.
Advanced Enzymes Technologies Ltd
Amano Enzymes, Inc.
F. Hoffmann-La Roche Ltd
Sekisui Chemical Co., Ltd.
Thermo Fisher Scientific, Inc.
Polymerases and Nucleases
Research & Biotechnology
Middle East & Africa
The Healthcare Specialty Enzymes market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Healthcare Specialty Enzymes market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Healthcare Specialty Enzymes market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Healthcare Specialty Enzymes market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Healthcare Specialty Enzymes market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Healthcare Specialty Enzymes capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Healthcare Specialty Enzymes by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Healthcare Specialty Enzymes market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Healthcare Specialty Enzymes market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Healthcare Specialty Enzymes market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Healthcare Specialty Enzymes industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Healthcare Specialty Enzymes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Healthcare Specialty Enzymes market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Healthcare Specialty Enzymes market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Healthcare Specialty Enzymes market. These factors have benefited the growth of the global market for Healthcare Specialty Enzymes. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Healthcare Specialty Enzymes. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Healthcare Specialty Enzymes are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Clinical Trial Equipment & Ancillary Solutions Market (By Product: Sourcing, Supply/Logistics, Service, Others; By Phase: Phase I, Phase II, Phase III, Phase IV) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Suction Systems Market (By Product: Wet Suction, Dry Suction; By End-use: Hospitals, Dental Offices) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Caries Detectors Market (By Product: Laser Fluorescent Caries Detector, Fiber Optic Trans-illumination Caries Detector; By End-use: Hospitals, Dental Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Ophthalmic Perimeters Market (By Product: Static, Kinetic, Combination; By End-use: Hospital, Ophthalmic Clinic, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Investigational New Drug CDMO Market (By Product: Small Molecule, Large Molecule; By Service: Contract Development, Contract Manufacturing; By End-use: Pharmaceutical Companies, Biotech Companies, Others (Government, Research Institutes, Academic Institutes, etc.)) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...